Biotech Stocks: Seeing Rainbows, Missing The Rain

The Nasdaq iShares Biotechnology Index, by YCharts
This week’s 10% drop in the Nasdaq iShares’ Biotechnology Index — not to mention the fact that biotech stocks, after a torrid two years, are up less than 4%  year-to-date — has investors worrying that the sector’s two-year boom is over.

http://www.forbes.com/sites/matthewherper/2014/03/27/three-misplaced-assumptions-that-could-end-the-biotech-boom/

About the Author

has written 23404 stories on this site.

Copyright © 2010 corporatecommunicationsnews101.com